- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: anti-CD5 CAR
Total 245506 results
-
iCell Gene TherapeuticsPeking University Shenzhen Hospital; iCAR Bio Therapeutics Ltd.RecruitingT-cell Acute Lymphoblastic Leukemia | T-cell Non-Hodgkin LymphomaChina
-
Xuanwu Hospital, BeijingBaoding Children's HospitalRecruitingT-cell Acute Lymphoblastic LeukemiaChina
-
Beijing GoBroad HospitalNot yet recruitingAcute Lymphoblastic Leukemia, in Relapse | Refractory Acute Lymphoblastic Leukemia | T-Cell Acute Lymphocytic Leukemia
-
University of North Carolina, Chapel HillNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)SuspendedANCA Associated VasculitisUnited States
-
Shenzhen Second People's HospitalUnknownMultiple Myeloma in RelapseChina
-
Loewenstein HospitalMeir Medical CenterUnknown
-
BioMérieuxCompletedMalaria | Dengue | ChikungunyaBurkina Faso, Côte D'Ivoire
-
PharmAbcineMerck Sharp & Dohme LLC; Novotech (Australia) Pty LimitedNot yet recruitingAdvanced or Metastatic Solid TumorsAustralia
-
Essen BiotechNot yet recruitingT Cell Lymphoma | T Cell Prolymphocytic Leukemia | T-cell Acute Lymphoblastic Leukemia | T Cell Leukemia | T-Cell Lymphoma of CNS | T Cell Childhood ALLChina
-
Kite, A Gilead CompanyArcellx, Inc.RecruitingRelapsed and Refractory Multiple MyelomaUnited States
-
United Nations Office on Drugs and Crime (UNODC)Polytechnique University of the Philippines; Anti-Drug Abuse Councils, LGUs...Enrolling by invitationFamily Relationship | Parenting SkillsPhilippines
-
Beijing Boren HospitalRecruitingT-Cell Acute Lymphoblastic LeukemiaChina
-
Beijing Boren HospitalRecruitingT-Cell Acute Lymphoblastic Leukemia/LymphomaChina
-
Centre Hospitalier Universitaire de Saint EtienneMinistry of Health, FranceRecruiting
-
University Hospital, BordeauxCompletedButton Battery PoisoningFrance
-
R3 Stem CellR3 Medical ResearchRecruitingLow Back PainUnited States
-
University of OxfordNational Institute for Health Research, United Kingdom; 180 Life SciencesCompletedFrozen ShoulderUnited Kingdom
-
University Hospital, BordeauxCompletedCOVID-19 | Neuromuscular Diseases | AmyotrophyFrance
-
Pierre Fabre Dermo CosmetiqueCompleted
-
JLLC NatiVitaNational Anti Doping Laboratory, BelarusNot yet recruiting
-
Pharmtechnology LLCNational Anti-Doping LabaratoryCompleted
-
Peking University Third HospitalRecruitingProliferative Diabetic RetinopathyChina
-
Emory UniversityNational Cancer Institute (NCI)Completed
-
Institut de Recherche pour le DeveloppementCompleted
-
Texas Tech UniversityCompleted
-
Northwestern UniversityCompleted
-
Centre Oscar LambretHôpital Gériatrique Les Bateliers, CHRU LilleCompleted
-
RenJi HospitalCompleted
-
Beckman Coulter, Inc.Completed
-
Abramson Cancer Center at Penn MedicineXencor, Inc.Active, not recruiting
-
University Hospital, MontpellierCompletedPatients Recieving Anti-PD-1 or Anti-PD-L1 ImmunotherapiesFrance
-
AllerganCompletedBlue Light DamageUnited States
-
McDaniel Institute of Anti-Aging ResearchAllergan; Merz Aesthetics Inc.; ThermiGen, LLCUnknown
-
Cynosure, Inc.Completed
-
Centre Hospitalier Universitaire de NīmesCompletedPediatric Population | Anti InfectiveFrance
-
Janssen Research & Development, LLCCompleted
-
Ohio State University Comprehensive Cancer CenterCompletedLymphoma, Small Lymphocytic | Lymphocytic Leukemia, ChronicUnited States
-
Assistance Publique - Hôpitaux de ParisRecruitingAntihypertensive Drugs in ICUFrance
-
Universitaire Ziekenhuizen KU LeuvenCompletedMandibular Prosthesis UserBelgium
-
University Hospital DubravaCompleted
-
Tetraphase Pharmaceuticals, Inc.Department of Health and Human ServicesCompletedNormal Drug ToleranceUnited States
-
Daniela Matei, MDMerck Sharp & Dohme LLC; Hoosier Cancer Research NetworkCompletedEndometrial Cancer | Endometrial AdenocarcinomaUnited States
-
National Institute of Environmental Health Sciences...Completed
-
University Hospital, BordeauxCompleted
-
Cardiovascular Academy Society, TurkeyCompleted
-
Kamada, Ltd.Completed
-
Humanis Saglık Anonim SirketiCompleted
-
Assistance Publique - Hôpitaux de ParisCompleted
-
University of GeorgiaRecruitingMessage Exposure (Sequence: Regular Then Flavor) | Message Exposure (Sequence: Flavor Then Regular) | No Message Exposure (Control Condition)United States